Glaxosmithkline | Rentekostnader



Interest Expense On Debt Endring Dato
AbbVie USD 610M 19M 2024-12
Amgen USD 723M 24M 2025-03
AstraZeneca 429M 28M 2024-12
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 337M 9M 2024-12
Bristol-Myers Squibb USD 494M 2M 2025-03
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 243.7M 19M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Indivior 9M 1000K 2024-09
J&J USD 128M 9M 2025-03
Merck USD 313M 15M 2025-03
Novartis USD 275M 11M 2024-12
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Pfizer USD 654M 85M 2025-03
Prestige Brands USD 11.37M 908K 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda 31.6B 36.86B 2024-12
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
Zoetis USD 51M 6M 2024-12



Glaxosmithkline Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.